
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series

FTC pauses lawsuit against PBMs over insulin pricing
The Federal Trade Commission is pressing pause on its legal fight with major pharmacy benefit managers.
from the fight to #SaveIndiePharmacy
The biggest Pharmacy Benefit Managers (PBMs) are profiting by systematically underpaying independent drugstores, creating “pharmacy deserts” across the country.
The third in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs .
Here’s what to know about your pharmacy benefit manager and how to find out if you are being overcharged for medications.
The first in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs.
Pharmacy Benefit Managers (PBMs) are driving up drug costs for millions of people, employers and the government.
The second in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs.
The Federal Trade Commission is pressing pause on its legal fight with major pharmacy benefit managers.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.